Clinical Trials Directory

Trials / Completed

CompletedNCT03350685

Detection and Characteristic of Whipple Diseases in the Great Britany

Status
Completed
Phase
Study type
Observational
Enrollment
267 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Whipple's disease is a chronic systemic infection caused by ubiquitous bacterium Tropheryma wipplei on a genetic predisposition which should be considered in patients with recurrent episodes of seronegative arthritis, erosive or not, or inflammatory low back pain, chronic diarrhea, persistent fever, unexplained neurological signs, uveitis, endocarditis, and epithelioid granuloma. Laboratory tests may show malabsorption, erythrocyte sedimentation rate and C-reactive protein elevation, anemia, thrombocytosis, eosinophilia and lymphopenia. None of theses findings is specific and most patients have arthritis or low back pain mimicking rheumatoid arthritis and spondyloarthritis. As the disease is rare, chance for positive polymerase chain reaction testing for Tropheryma whipplei is low in this context.

Conditions

Timeline

Start date
2017-11-15
Primary completion
2018-02-09
Completion
2018-02-09
First posted
2017-11-22
Last updated
2018-02-13

Locations

8 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03350685. Inclusion in this directory is not an endorsement.